Sefdin - Cefazolin, also known as cefazoline or cephazolin, is a first generation cephalosporin antibiotic.
The drug is usually administrated either by intramuscular injection (injection into a large muscle) or intravenous infusion (intravenous fluid into a vein).
Sefdin is an antibiotic. It is used to treat certain bacterial infections of the nose, throat, chest, ears or skin. Sefdin belongs to a group of antibiotics called the cephalosporins.
Indications: bacterial infections
Sefdin (marketed by Abbott Laboratories under the brand name Omnicef) is a semi-synthetic, broad-spectrum antibiotic in the third generation of the cephalosporin class, proven effective for common bacterial infections of the ear, sinus, throat, and skin. It was approved by the U.S. Food and Drug Administration (FDA) in December 1997.
Indications: Gynecological and moderate to severe intra abdominal infections,bacteremia, septicaemia, lower respiratory tract infection, severe pneumonia, febrile neutropenia, acute leukemia, urinary tract infections (UTI).
Indications: Community acquired pneumonia, otitis media, pharyngitis, tonsilitis, LRTI, Acute maxillary sinusitis, switch therapy, Acute exacerbation of chronic bronchitis, uncomplicated skin infections.